The western blot results showed that DMOG treatment could further increase the expression of HIF-1α in diabetic mice, but 2-ME inhibited the increase of HIF-1α induced by hyperglycemia (Figures 1(a) and 1(b)). The gene discussed is HIF1A; the disease is Hyperglycemia.